Literature DB >> 1637252

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

R L Spitzer1, J B Williams, M Gibbon, M B First.   

Abstract

The history, rationale, and development of the Structured Clinical Interview for DSM-III-R (SCID) is described. The SCID is a semistructured interview for making the major Axis I DSM-III-R diagnoses. It is administered by a clinician and includes an introductory overview followed by nine modules, seven of which represent the major axis I diagnostic classes. Because of its modular construction, it can be adapted for use in studies in which particular diagnoses are not of interest. Using a decision tree approach, the SCID guides the clinician in testing diagnostic hypotheses as the interview is conducted. The output of the SCID is a record of the presence or absence of each of the disorders being considered, for current episode (past month) and for lifetime occurrence.

Entities:  

Mesh:

Year:  1992        PMID: 1637252     DOI: 10.1001/archpsyc.1992.01820080032005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  961 in total

1.  Early transference interventions with male patients in psychotherapy.

Authors:  E Banon; M Evan-Grenier; M Bond
Journal:  J Psychother Pract Res       Date:  2001

2.  Prefrontal dopamine D1 receptors and working memory in schizophrenia.

Authors:  Anissa Abi-Dargham; Osama Mawlawi; Ilise Lombardo; Roberto Gil; Diana Martinez; Yiyun Huang; Dah-Ren Hwang; John Keilp; Lisa Kochan; Ronald Van Heertum; Jack M Gorman; Marc Laruelle
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

3.  Recruiting phobic research subjects: effectiveness and cost.

Authors:  T Kaakko; H Murtomaa; P Milgrom; T Getz; D S Ramsay; S E Coldwell
Journal:  Anesth Prog       Date:  2001

4.  Cluster C personality disorder has no independent effect on striatal dopamine transporter densities in major depression.

Authors:  T Laasonen-Balk; H Viinamäki; J Kuikka; M Husso-Saastamoinen; J Lehtonen; P Halonen; J Tiihonen
Journal:  Psychopharmacology (Berl)       Date:  2001-04       Impact factor: 4.530

5.  Assessing readiness for change among persons with severe mental illness.

Authors:  E S Rogers; R Martin; W Anthony; J Massaro; K Danley; T Crean; W Penk
Journal:  Community Ment Health J       Date:  2001-04

6.  Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.

Authors:  Roman Kotov; Laura Fochtmann; Kaiqiao Li; Marsha Tanenberg-Karant; Eduardo A Constantino; Joan Rubinstein; Greg Perlman; Eva Velthorst; Anne-Kathrin J Fett; Gabrielle Carlson; Evelyn J Bromet
Journal:  Am J Psychiatry       Date:  2017-08-04       Impact factor: 18.112

7.  Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease.

Authors:  S E Starkstein; L Sabe; S Vázquez; G Di Lorenzo; A Martínez; G Petracca; A Tesón; E Chemerinski; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

8.  Pharmacogenomics of sterol synthesis and statin use in schizophrenia subjects treated with antipsychotics.

Authors:  Thomas J Vassas; Kyle J Burghardt; Vicki L Ellingrod
Journal:  Pharmacogenomics       Date:  2014-01       Impact factor: 2.533

9.  Externalizing disorders in the offspring from the San Diego prospective study of alcoholism.

Authors:  Marc A Schuckit; Tom L Smith; Juliann Pierson; Ryan Trim; George P Danko
Journal:  J Psychiatr Res       Date:  2007-08-31       Impact factor: 4.791

10.  Delusions are associated with poor cognitive insight in schizophrenia.

Authors:  John A Engh; Svein Friis; Astrid B Birkenaes; Halldóra Jónsdóttir; Ole Klungsøyr; Petter A Ringen; Carmen Simonsen; Anja Vaskinn; Stein Opjordsmoen; Ole A Andreassen
Journal:  Schizophr Bull       Date:  2009-01-27       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.